Adage Capital Partners’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Adage Capital Partners’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-150,000	Closed	-$2.53M	–	762
2014 Q4	$2.53M	Sell	150,000 -450,000	-75%	-$6.55M	0.01%	662
2014 Q3	$8.05M	Hold	600,000	–	–	0.02%	563
2014 Q2	$7.64M	Sell	600,000 -100,000	-14%	-$1.04M	0.02%	564
2014 Q1	$8.32M	Buy	+700,000	New	+$9.39M	0.02%	537

Other funds holding INFI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Adage Capital Partners's INFI Position: Q1 2015 in Review

Adage Capital Partners sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2015, closing a stake of 150,000 shares — an estimated $2.53M sold.

Adage Capital Partners first reported a position in INFI in Q1 2014 and held it in 4 quarters. The position peaked at $8.32M in Q1 2014. 141 funds tracked by Wall St. Rank hold INFI as of Q1 2015.

Adage Capital Partners reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2015 after selling out during the quarter.
Adage Capital Partners sold 150,000 Infinity Pharmaceuticals, Inc. shares in Q1 2015, an estimated $2.53M.
Adage Capital Partners first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2014 and held it in 4 quarters.
Adage Capital Partners's Infinity Pharmaceuticals, Inc. position peaked at $8.32M in Q1 2014.
141 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2015.

Based on Adage Capital Partners's 13F filing for Q1 2015, filed 15 May 2015.